Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease

By sjmartinez • February 1, 2025

Yan A, Madigan L, Korman A, Shearer S, Dulmage B, Patel T, Milani-Nejad N, Chung C, Fisher K, Kaffenberger B. Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease. Am J Clin Dermatol. 2025 Jan 31. doi: 10.1007/s40257-025-00924-0. Epub ahead of print. PMID: 39888589.

Tags: Dermatology, Publications

Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology

Ebriani J, Yan MJ, Lester J, Farshchian M, Wongvibulsin S. Ethical considerations regarding environmental impact of generative artificial intelligence (AI) in dermatology. J Am Acad[...]

Autoimmune Bullous Diseases: Therapeutic Update

Kasperkiewicz M, van Beek N, Schmidt E. Autoimmune Bullous Diseases: Therapeutic Update. Drugs. 2026 Feb 23. doi: 10.1007/s40265-026-02292-3. Epub ahead of print. PMID: 41729378.

Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study

Bunick CG, Vleugels RA, Lebwohl M, Armstrong AW, Grada A, Yue EX, Saranadasa M, Wegrzyn L, D'Andrea E. Systemic Corticosteroid Exposure in Patients with Atopic[...]